Donna Carr

2.9k total citations
17 papers, 1.0k citations indexed

About

Donna Carr is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Donna Carr has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Donna Carr's work include Melanoma and MAPK Pathways (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Pneumonia and Respiratory Infections (3 papers). Donna Carr is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Pneumonia and Respiratory Infections (3 papers). Donna Carr collaborates with scholars based in United States and United Kingdom. Donna Carr's co-authors include Paul T. Kirschmeier, Linda James, W. Robert Bishop, Kimberly Gray, Hena R. Ashar, Lydia Armstrong, Stuart Black, William T. Windsor, Richard Bond and Lynn Wang and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Donna Carr

17 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Carr United States 12 732 401 123 121 97 17 1.0k
Ashutosh Pal United States 16 525 0.7× 340 0.8× 130 1.1× 51 0.4× 30 0.3× 44 983
Anne Marinier Canada 19 686 0.9× 162 0.4× 186 1.5× 61 0.5× 44 0.5× 52 1.1k
Dale Grabowski United States 22 1.1k 1.5× 650 1.6× 157 1.3× 128 1.1× 50 0.5× 67 1.4k
David A. Janowick United States 11 539 0.7× 209 0.5× 126 1.0× 326 2.7× 27 0.3× 14 814
Paul Fleming United States 12 958 1.3× 455 1.1× 395 3.2× 83 0.7× 85 0.9× 23 1.4k
Christopher J. Stubbs United Kingdom 15 509 0.7× 158 0.4× 67 0.5× 115 1.0× 85 0.9× 33 785
A. Kathleen McClendon United States 17 904 1.2× 937 2.3× 175 1.4× 116 1.0× 43 0.4× 20 1.6k
Kanda Sangthongpitag Singapore 15 629 0.9× 245 0.6× 76 0.6× 53 0.4× 20 0.2× 25 827
Enrica Favini Italy 16 450 0.6× 180 0.4× 71 0.6× 122 1.0× 24 0.2× 23 668
Eva‐Laure Matera France 16 355 0.5× 314 0.8× 145 1.2× 66 0.5× 44 0.5× 32 815

Countries citing papers authored by Donna Carr

Since Specialization
Citations

This map shows the geographic impact of Donna Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Carr more than expected).

Fields of papers citing papers by Donna Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Carr. The network helps show where Donna Carr may publish in the future.

Co-authorship network of co-authors of Donna Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Carr. A scholar is included among the top collaborators of Donna Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Carr. Donna Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Carr, Donna, Huong Trinh, Fred Racine, et al.. (2022). Development of a fully automated platform for agar-based measurement of viable bacterial growth. SLAS TECHNOLOGY. 27(4). 247–252. 1 indexed citations
2.
Carr, Donna, Zufei Zhang, Qian Si, et al.. (2020). In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas Aeruginosa. Open Forum Infectious Diseases. 7(11). ofaa469–ofaa469. 3 indexed citations
3.
Zhang, Zufei, Fred Racine, Donna Carr, et al.. (2019). A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactam. International Journal of Infectious Diseases. 89. 55–61. 35 indexed citations
4.
Asante‐Appiah, Ernest, Rong Liu, Stephanie Curry, et al.. (2018). In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A. Antimicrobial Agents and Chemotherapy. 62(11). 4 indexed citations
5.
Wu, Jin, Fred Racine, Michael K. Wismer, et al.. (2018). Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 62(5). 46 indexed citations
6.
Walker, Scott S., David Degen, Elliott Nickbarg, et al.. (2017). Affinity Selection–Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor. ACS Chemical Biology. 12(5). 1346–1352. 14 indexed citations
7.
Zhu, Hugh, Jagdish Desai, Yongqi Deng, et al.. (2015). Discovery of hydroxyaniline amides as selective Extracellular Regulated Kinase (Erk) inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(7). 1627–1629. 9 indexed citations
8.
Deng, Yongqi, Gerald W. Shipps, Alan Cooper, et al.. (2014). Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an Inactive Kinase. Journal of Medicinal Chemistry. 57(21). 8817–8826. 38 indexed citations
9.
Fischmann, Thierry, Catherine K. Smith, Todd Mayhood, et al.. (2009). Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors. Biochemistry. 48(12). 2661–2674. 145 indexed citations
10.
Smith, Catherine K., Donna Carr, Todd Mayhood, et al.. (2006). Expression and purification of phosphorylated and non-phosphorylated human MEK1. Protein Expression and Purification. 52(2). 446–456. 13 indexed citations
11.
Ashar, Hena R., Linda James, Kimberly Gray, et al.. (2001). The Farnesyl Transferase Inhibitor SCH 66336 Induces a G2 → M or G1 Pause in Sensitive Human Tumor Cell Lines. Experimental Cell Research. 262(1). 17–27. 92 indexed citations
12.
Ashar, Hena R., Linda James, Kimberly Gray, et al.. (2000). Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the Microtubules. Journal of Biological Chemistry. 275(39). 30451–30457. 261 indexed citations
13.
Ashar, Hena R., Lydia Armstrong, Linda James, et al.. (2000). Biological Effects and Mechanism of Action of Farnesyl Transferase Inhibitors. Chemical Research in Toxicology. 13(10). 949–952. 12 indexed citations
14.
Afonso, Adriano, Jay Weinstein, Joseph Kelly, et al.. (1999). Analogues of 1-(3,10-Dibromo-8-chloro-6,11-dihydro-5 H -benzo[5,6]-cyclohepta[1,2- b ]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase. Bioorganic & Medicinal Chemistry. 7(9). 1845–1855. 8 indexed citations
15.
Kirschmeier, Paul T., Donna Carr, Linda James, et al.. (1997). Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type I. Journal of Biological Chemistry. 272(15). 10232–10239. 167 indexed citations
16.
Bishop, W. Robert, Richard Bond, Joanne Petrin, et al.. (1995). Novel Tricyclic Inhibitors of Farnesyl Protein Transferase. Journal of Biological Chemistry. 270(51). 30611–30618. 129 indexed citations
17.
McCombie, Stuart W., Donna Carr, Michael P. Kirkup, et al.. (1993). Indolocarbazoles. 1. Total synthesis and protein kinase inhibiting characteristics of compounds related to K-252c.. Bioorganic & Medicinal Chemistry Letters. 3(8). 1537–1542. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashutosh Pal Breakdown of academic impact, for papers by Anne Marinier Breakdown of academic impact, for papers by Dale Grabowski Breakdown of academic impact, for papers by David A. Janowick Breakdown of academic impact, for papers by Paul Fleming Breakdown of academic impact, for papers by Christopher J. Stubbs Breakdown of academic impact, for papers by A. Kathleen McClendon Breakdown of academic impact, for papers by Kanda Sangthongpitag Breakdown of academic impact, for papers by Enrica Favini Breakdown of academic impact, for papers by Eva‐Laure Matera
Rankless by CCL
2026